Thursday, October 17, 2019
wellness India Expo
Home Tags Cipla

Tag: Cipla

Alvotech & Cipla Gulf join hands to commercialize key biosimilar in...

Under the partnership, Alvotech will be responsible for development and supply of AVT02, an adalimumab biosimilar, in select emerging markets., while Cipla Gulf will be responsible for registration and commercialization....................

Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI

Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................

22 drugs in the market without approval, govt sends notices to...

The NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation....................

Cipla EU & Jiangsu Acebright enter into a joint venture

According to the agreement, Cipla EU will hold an 80% stake and Acebright will hold a 20% stake in it for a combined investment of USD 30mn. Upon incorporation, the JV Co will set up a manufacturing facility for local manufacture of respiratory products.............

Cipla appoints Dr Raju Mistry as Global Chief People Officer

In her role at Cipla, Raju will oversee Human Resources, and Administration and Facilities Management......................

Cipla Medpro acquires a stake in connected health company, Brandmed

As per Cipla's top management, by combining strengths with Brandmed’s innovative, patient centric approach to healthcare, Cipla Medpro will enhance its diverse portfolio in the NCD area to provide holistic care to patients..................

Inspirational Science Programme gets funding boost from Cipla chairman

Generous donation of Rs. 8.7 crore has been committed to the Inspirational Science Programme across India that aims to give Indian teachers new tools for delivering engaging and effective science lessons, and to encourage students to reach.........

Cipla & Wellthy Therapeutics partner to offer digital therapeutics for diabetes...

The platform brings together behavioural science, real-world clinical evidence and artificial intelligence to provide real-time monitoring, coaching and advice to patients, and virtual clinical assistance to doctors...…………...

Growing number of athma patients in India a cause of worry!

The horrifying figures around asthma are a result of poor management. If the disease is managed properly, the patient can live a healthy life without any barriers..............

InvaGen to acquire Avenue Therapeutics for specialty hospital business in the...

At the first stage closing, InvaGen or its affiliates will acquire, through the issuance by Avenue of new shares, shares representing a 33.3% stake in Avenue’s capital stock on a fully diluted basis for $35 million...…………...